JP2013541588A5 - - Google Patents

Download PDF

Info

Publication number
JP2013541588A5
JP2013541588A5 JP2013537811A JP2013537811A JP2013541588A5 JP 2013541588 A5 JP2013541588 A5 JP 2013541588A5 JP 2013537811 A JP2013537811 A JP 2013537811A JP 2013537811 A JP2013537811 A JP 2013537811A JP 2013541588 A5 JP2013541588 A5 JP 2013541588A5
Authority
JP
Japan
Prior art keywords
degrees
pyrrolo
pyrimidin
aminomethyl
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013537811A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013541588A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/059086 external-priority patent/WO2012061565A1/en
Publication of JP2013541588A publication Critical patent/JP2013541588A/ja
Publication of JP2013541588A5 publication Critical patent/JP2013541588A5/ja
Pending legal-status Critical Current

Links

JP2013537811A 2010-11-05 2011-11-03 3−(4−(アミノメチル)−1−(5−メチル−7H−ピロロ[2,3−d]ピリミジン−4−イル)ピペリジン−4−カルボキサミド)フェニルジメチルカルバメートの固体形態 Pending JP2013541588A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41060210P 2010-11-05 2010-11-05
US61/410,602 2010-11-05
PCT/US2011/059086 WO2012061565A1 (en) 2010-11-05 2011-11-03 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate

Publications (2)

Publication Number Publication Date
JP2013541588A JP2013541588A (ja) 2013-11-14
JP2013541588A5 true JP2013541588A5 (enExample) 2014-12-04

Family

ID=45002136

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013537811A Pending JP2013541588A (ja) 2010-11-05 2011-11-03 3−(4−(アミノメチル)−1−(5−メチル−7H−ピロロ[2,3−d]ピリミジン−4−イル)ピペリジン−4−カルボキサミド)フェニルジメチルカルバメートの固体形態

Country Status (16)

Country Link
US (1) US8735408B2 (enExample)
EP (1) EP2635584A1 (enExample)
JP (1) JP2013541588A (enExample)
KR (1) KR20140003433A (enExample)
CN (1) CN103298815A (enExample)
AR (1) AR083756A1 (enExample)
AU (1) AU2011323371A1 (enExample)
BR (1) BR112013011094A2 (enExample)
CA (1) CA2817112A1 (enExample)
IL (1) IL225884A0 (enExample)
MX (1) MX2013004923A (enExample)
RU (1) RU2013125755A (enExample)
SG (1) SG190098A1 (enExample)
TW (1) TW201302754A (enExample)
WO (1) WO2012061565A1 (enExample)
ZA (1) ZA201302996B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015150337A1 (en) 2014-04-01 2015-10-08 Amakem Nv Lim kinase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI439457B (zh) * 2007-09-28 2014-06-01 Lexicon Pharmaceuticals Inc (s)-2-胺基-3-(4-(2-胺基-6-((r)-1-(4-氯-2-(3-甲基-1h-吡唑-1-基)苯基)-2,2,2-三氟乙氧)-嘧啶-4-基)苯基)丙酸乙酯之固體形式與其使用方法
KR101706391B1 (ko) * 2008-04-21 2017-02-13 렉시컨 파마슈티컬스 인코퍼레이티드 Limk2 억제제, 그를 포함하는 조성물 및 그의 사용 방법

Similar Documents

Publication Publication Date Title
RU2430099C2 (ru) Тозилатная соль терапевтического соединения и ее фармацевтические композиции
AU2017242867B2 (en) Vortioxetine pamoic acid salt and crystal form thereof
JP6559719B2 (ja) (s)−6−((1−アセチルピペリジン−4−イル)アミノ)−n−(3−(3、4−ジヒドロイソキノリン−2(1h)−イル)−2−ヒドロキシプロピル)ピリミジン−4−カルボキサミドの結晶塩
WO2019141179A1 (zh) 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用
JP2018515495A5 (enExample)
JP2009542613A5 (enExample)
CN104244948B (zh) 在炎症性疾病的治疗中使用的用于调节n-酰基乙醇胺的特异性酰胺酶的组合物和方法
ES2614612T3 (es) Derivados de quinazolinona útiles como antagonistas de vanilloides
JP2015503595A5 (enExample)
RU2011121876A (ru) Пиразолопиримидиновые соединения-ингибиторы jak и способы
PH12018550049A1 (en) Protein kinase inhibitor, preparation method and medical use thereof
JP2017533968A5 (enExample)
GEP20125621B (en) 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
JP2015526487A5 (enExample)
RU2014123567A (ru) Кристаллическая 7{(3s, 4s)-3-[(циклопропиламино)метил]-4-фторпирролидин-1-ил}-6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1, 4-дигидрохинолин-3-карбоновая кислота
JP2012144537A5 (enExample)
EA031614B1 (ru) Трициклические атропоизомерные соединения
JP2013511475A5 (enExample)
JP2009040767A5 (enExample)
CN107530349A (zh) 作为a2b拮抗剂的黄嘌呤取代的炔基氨基甲酸酯/反式氨基甲酸酯
RU2013125756A (ru) Твердые формы (s)-2-амино-3-(4-(2-амино-6-((r)-1-(4-хлор-2-(3-метил-1н-пиразол-1-ил)фенил)-2,2,2-трифторэтокси)пиримидин-4-ил)фенил)пропановой кислоты
JP2011524915A (ja) (1r,2s,3r)−1−(2−(イソオキサゾール−3−イル)−1h−イミダゾール−4−イル)ブタン−1,2,3,4−テトラオールの固体形態及びその使用方法
WO2014180327A1 (zh) 苯酚衍生物及其制备方法和在医药上的应用
JP2013541588A5 (enExample)
TW200934774A (en) Arylmethylidene heterocycles as novel analgesics